PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5421.62M
Enterprise Value 3370.86M
Trailing P/E N/A
Forward P/E 1-9.68
PEG Ratio (5 yr expected) 1-0.02
Price/Sales (ttm)33.84
Price/Book (mrq)7.02
Enterprise Value/Revenue 329.76
Enterprise Value/EBITDA 6-7.21

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-421.23%

Management Effectiveness

Return on Assets (ttm)-21.18%
Return on Equity (ttm)-64.95%

Income Statement

Revenue (ttm)12.46M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)-95.00%
Gross Profit (ttm)69.43M
EBITDA -51.44M
Net Income Avi to Common (ttm)-55.55M
Diluted EPS (ttm)-0.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.28M
Total Cash Per Share (mrq)1.4
Total Debt (mrq)49.62M
Total Debt/Equity (mrq)82.60
Current Ratio (mrq)7.85
Book Value Per Share (mrq)0.86

Cash Flow Statement

Operating Cash Flow (ttm)-49.04M
Levered Free Cash Flow (ttm)-31.02M

Trading Information

Stock Price History

Beta 3.17
52-Week Change 3-42.24%
S&P500 52-Week Change 314.33%
52 Week High 311.72
52 Week Low 34.60
50-Day Moving Average 36.02
200-Day Moving Average 36.11

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 3887.43k
Shares Outstanding 570.27M
Float 66.39M
% Held by Insiders 10.59%
% Held by Institutions 184.58%
Shares Short 36.73M
Short Ratio 37.35
Short % of Float 317.06%
Shares Short (prior month) 37.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A